COPD Clinical Trial 20213119

[LCID Study Number: 20213119]

A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients With COPD

The purpose of this study is to assess the safety and effectiveness of bronchial rheoplasty for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis.

Disease/Condition: COPD

Department: Pulmonary and Critical Care

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

View NCT ID 04677465 on ClinicalTrials.gov
Protocol #: 20213119
Principal Investigator(s): Carla R. Lamb
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Category A Device